Effectiveness and safety of ivabradine in Chinese patients with chronic heart failure: an observational study.

Jingmin ZhouYamei XuZhaofen ZhengShuyang ZhangJiefu YangYuhui ZhangBaopeng TangHuiyuan HanQing ZhangFan LiuWenhui DingCaizhen QianGuohai SuXiaohui LiuYuansheng ShenBei ShiXiangqing KongZhiming GePing ZhangXiaomei GuoHong ZhangYuemin SunYugang DongGuosheng FuLei FengJun-Bo Genull null

Published in: ESC heart failure (2024)

Ivabradine treatment reduced HR and improved cardiac function and health-related quality of life in Chinese patients with chronic HF. Benefits were seen irrespective of whether or not patients were also taking ARNIs or beta-blockers. Treatment was well tolerated with a similar profile to previous ivabradine studies.

Keyphrases

ejection fraction
heart rate
end stage renal disease
newly diagnosed
chronic kidney disease
heart failure
replacement therapy
acute heart failure
smoking cessation